- Home
- PCVX vs HQY Comparison
PCVX vs HQY Comparison
Compare PCVX & HQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- HQY
- Stock Information
- Founded
- PCVX 2013
- HQY 2002
- Country
- PCVX United States
- HQY United States
- Employees
- PCVX N/A
- HQY N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- HQY Business Services
- Sector
- PCVX Health Care
- HQY Consumer Discretionary
- Exchange
- PCVX Nasdaq
- HQY Nasdaq
- Market Cap
- PCVX 4.5B
- HQY 8.7B
- IPO Year
- PCVX 2020
- HQY 2014
- Fundamental
- Price
- PCVX $31.16
- HQY $90.40
- Analyst Decision
- PCVX Strong Buy
- HQY Strong Buy
- Analyst Count
- PCVX 10
- HQY 12
- Target Price
- PCVX $136.50
- HQY $111.75
- AVG Volume (30 Days)
- PCVX 2.2M
- HQY 842.8K
- Earning Date
- PCVX 05-07-2025
- HQY 06-02-2025
- Dividend Yield
- PCVX N/A
- HQY N/A
- EPS Growth
- PCVX N/A
- HQY 70.31
- EPS
- PCVX N/A
- HQY 1.09
- Revenue
- PCVX N/A
- HQY $1,199,774,000.00
- Revenue This Year
- PCVX N/A
- HQY $9.60
- Revenue Next Year
- PCVX N/A
- HQY $10.04
- P/E Ratio
- PCVX N/A
- HQY $82.73
- Revenue Growth
- PCVX N/A
- HQY 20.03
- 52 Week Low
- PCVX $27.66
- HQY $65.01
- 52 Week High
- PCVX $121.06
- HQY $115.59
- Technical
- Relative Strength Index (RSI)
- PCVX 36.73
- HQY 55.09
- Support Level
- PCVX $28.09
- HQY $89.30
- Resistance Level
- PCVX $33.75
- HQY $93.20
- Average True Range (ATR)
- PCVX 2.54
- HQY 2.90
- MACD
- PCVX 1.12
- HQY 1.09
- Stochastic Oscillator
- PCVX 35.61
- HQY 76.61
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About HQY HealthEquity Inc.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.